Comparison of Point-Of-Care testing and venouS blood glucose at the oral Glucose TolerAnce test in pRegnancy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON24013

Enrollment

330

Registered

2021-03-10

Start date

2021-06-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes, Pregnancy

Interventions

Capillary blood sampling in addition to venous sampling

Eligibility

Inclusion criteria

Inclusion criteria: 12-40 weeks pregnant Indication for OGTT

Exclusion criteria

Exclusion criteria: Unable to read informed consent in Dutch or English Pre-gestational diabetes mellitus (type I or II) Using glucose lowering medication (for example Metformin or Glyburide) History of bariatric surgery with dumping in the past

Design outcomes

Primary

Measure	Time frame
Level of agrement between plasma levels and capillary samples.	—

Secondary

Measure	Time frame
To determine the number of diagnosed patients with GDM detected by POCT. To evaluate whether adjusted cut-offs for the POCT can be found to minimize false-positive and false-negative results compared to venous blood sampling.	—

Contacts

Public ContactJonas Ellerbrock

Zuyderland Medisch Centrum

j.ellerbrock@zuyderland.nl088-4597777

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)